Statement issued by the Boots Pure Drug Company on Boots brand insulin
Boots Company Limited
6 p. ; 20 x 12 cm.
Item is a statement, prepared in pamphlet form, describing the Boots Pure Drug Company's brand of insulin, Insulin - Boots. Headings: 'The Insulin Treatment of Diabetes Mellitus. Type of Case and Conditions necessary for the treatment. Coma. Hypoglycaemic Reaction. Mode of Administration. Dosage.' Following first heading: 'This statement has been prepared under the direction of the Medical Research Council.'
University of Toronto Archives. A1982-0001, Box 11, Folder 5
Title based on content of item.
Paragraph 20 of the agreement between the Governors of the University of Toronto and licensees for a foreign export license compelled the licensees to supply to the University of Toronto copies in duplicate of all advertisements and literature relating to the insulin they offered for sale.
Boots Company LimitedMedical Research Council (Great Britain)Insulin - Early manufacture - Great BritainInsulin - Advertisements